Bosaya (denosumab-kyqq) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat osteoporosis in women after menopause who are at high risk for fracture. It is also approved to increase bone mass in men with osteoporosis who are at high risk for fracture.
Bosaya is a type of medicine called a RANK ligand (RANKL) inhibitor. It blocks a protein called RANKL that helps control cells that break down bone. By blocking this protein, Bosaya slows bone breakdown and helps increase bone mass and strength.
Bosaya is a biosimilar of Prolia. This means it is made from living cells and is designed to work like the original medicine. The FDA requires biosimilars to have no meaningful differences in safety or how well they work.
Doctors prescribe Bosaya when:
Bosaya is given as an injection under the skin by a healthcare provider.
The recommended dose of Bosaya is 60 milligrams given as an injection under the skin once every six months.
People should receive 1,000 milligrams of calcium each day and at least 400 international units of vitamin D each day while receiving Bosaya.
This information is based on prescribing information, but your healthcare provider may tailor your treatment plan. Always follow their guidance.
In clinical studies of denosumab, the active ingredient in Prolia, the reference medicine for Bosaya, the most common side effects differed depending on why people were taking it.
In women with osteoporosis after menopause, common side effects include:
In men with osteoporosis, common side effects include:
In people with osteoporosis caused by corticosteroid medicines, common side effects include:
In people with bone loss related to certain prostate or breast cancer treatments, side effects include:
Bosaya has a boxed warning, the FDA’s strongest safety warning, about the risk of severe hypocalcemia in people with advanced chronic kidney disease. A boxed warning does not mean the drug is unsafe for everyone or that everyone faces the same level of risk.
Bosaya can cause serious side effects that may require immediate medical attention. These include:
Get medical help right away if you think you are having a serious reaction.
Biocon Biologics, the manufacturer of Bosaya, offers the Biocon Biologics Patient Assistance Program. Eligible people in the United States may be able to receive Bosaya at no cost.
To learn more, visit the Biocon Biologics Patient Assistance Program or call 844-224-6266.
Before you start Bosaya:
Tell your doctor if you are allergic to denosumab products or any of the ingredients in Bosaya.
Tell your doctor about all medicines you take, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.
Also tell your doctor if you:
Take good care of your teeth and gums while receiving Bosaya. Brush and floss regularly, and tell your dentist that you receive Bosaya before having dental work.
Do not take Bosaya if you:
Bosaya is also FDA-approved to increase bone mass in men at high risk for fracture who are receiving androgen deprivation therapy for prostate cancer that has not spread to other parts of the body. It is also approved to increase bone mass in women at high risk for broken bones who are receiving adjuvant aromatase inhibitor therapy as part of breast cancer care.
If you miss a dose, get the injection as soon as possible. After that, your next dose should be scheduled six months from the date of your last injection.
Do not take Bosaya if you are pregnant because it may cause fetal harm. If you can become pregnant, use effective birth control during treatment and for at least five months after your last dose. Tell your doctor right away if you become pregnant during treatment.
If you are breastfeeding or plan to breastfeed, tell your doctor. It is not known if Bosaya passes into breast milk. Do not breastfeed while receiving Bosaya.
These answers are fact-checked by our editorial staff.
How effective is Bosaya for osteoporosis?
In a three-year study of women with osteoporosis after menopause:
In a separate one-year study of men with osteoporosis:
How long does Bosaya take to work for osteoporosis?
Studies of denosumab showed that changes in bone breakdown began soon after treatment. One marker of bone breakdown, called serum type 1 C-telopeptide, decreased by about 85 percent within three days. The largest decreases were seen by one month.
In women with osteoporosis after menopause, denosumab significantly reduced new spine fractures at years 1, 2, and 3. It also significantly increased bone mineral density at measured bone sites after three years.
The studies do not say exactly when a person will notice Bosaya working.
Should I take Bosaya for osteoporosis if I have an infection?
Bosaya may increase the risk of serious infections. These can include infections of the skin, abdomen, urinary tract, or ear.
People who take medicines that weaken the immune system, or who already have a weakened immune system, may have a higher risk of serious infections. Your doctor should consider the benefits and risks of Bosaya before treatment.
If you develop a serious infection while receiving Bosaya, your doctor should decide whether you should continue treatment. Get medical care promptly if you develop signs or symptoms of a serious infection, including cellulitis, which is a serious skin infection.
On MyOsteoTeam, people share their experiences with osteoporosis, get advice, and find support from others who understand.
Learn more about Bosaya and osteoporosis care:
More resources from MyOsteoTeam that mention Bosaya
Become a member to get even more